Vered Stearns, MD

Highlights

1
NPJ breast cancer · 2022
VSVered Stearns
PMID: 35449210PMCID: PMC9023490DOISenior author32 citations
2
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2021
VSVered Stearns
PMID: 33999652PMCID: PMC8260904DOISenior author43 citations
3
Clinical cancer research : an official journal of the American Association for Cancer Research · 2020
VSVered Stearns
PMID: 32071117PMCID: PMC7299780DOISenior author44 citations

317

7 grants

MPI
Bridging Gaps and Transforming CARE for Young Breast Cancer Survivors and those with Metastatic Disease
Centers for Disease Control and Prevention · 2024–2029
No publications yet
NU58DP007916-03-00
PI
Dietary and Pharmacologic Interventions to Optimize Weight in Individuals with Breast Cancer
Breast Cancer Research Foundation · 2026–2028
BCRF-26-154
Sub-PI
Cardiac risks after contemporary radiation for breast cancer on prospective radiotherapy trials
Breast Cancer Research Foundation · 2026–2027 · via NRG Oncology
CONS-26-010
Co-I
Harnessing Innate Immunity and Radiotherapy for Next-Generation Immuno-Oncology in Metastatic Breast Cancer
METAvivor Research and Support, Inc. · 2025–2027
MRS 243992-01
MPI
NRG Oncology Network Group Operations Center
National Cancer Institute · 2023–2027 · via NRG Oncology· 2 renewals
U10CA180868-12
PI
Correlative biomarkers to optimize breast cancer treatment and prevention strategies
Breast Cancer Research Foundation · 2024–2026
BCRF-24-154
Sub-PI
Cardiac risks after contemporary radiation for breast cancer on prospective radiotherapy trials
Breast Cancer Research Foundation · 2024–2026 · via NRG Oncology
CONS-24-010

Completed grants (5)

PI
New Approaches to Breast Cancer Prevention
Breast Cancer Research Foundation · 2023–2024
BCRF-23-154
Sub-PI
Breast Cancer in Young Women-Thriving After a Diagnosis
Centers for Disease Control and Prevention · 2023–2024 · via The Johns Hopkins University
No publications yet
NU58DP006673-05-00
PI
Breast and Ovarian Cancer Program - 08
NCI · 1997–2022 · via NIH RePORTER
P30CA006973-58
PI
YOUNG WOMEN WITH BREAST CANCER PROGRAM AT JOHNS HOPKINS: SURVIVING AND THRIVING
NIH · 2014–2019 · via NIH RePORTER
No publications yet
U58DP005410-01
PI
THE EFFECTS OF 24 MONTHS OF EXEMESTANE OR LETROZOLE ON SURROGATE MARKERS
NCRR · 2006–2007 · via NIH RePORTER
M01RR000052-46

1

1 study

PI
A Phase III Adjuvant Trial Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25 (OFSET)
PHASE3 · NRG Oncology · OPEN TO ACCRUAL (as of 2024)
Breast Cancer
NCT05879926

CDC Grant Funds Initiatives for Breast Cancer Patients
January 6, 2025
The five-year, $2.3 million grant from the Centers for Disease Control and Prevention will seek to improve equitable access to care, quality of life and survival outcomes for young people with all stages of breast cancer.